Labshake search
Citations for R&D Systems :
101 - 150 of 1736 citations for Dengue Virus Serotype 4 NS1 Protein Insect Cells since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2019Quote: ... The cells were then incubated overnight at 4°C in buffer G with the following antibodies: mouse monoclonal anti-Tuj1 (R&D Systems, MAB1195) at 1:1000 ...
-
bioRxiv - Neuroscience 2021Quote: ... 0.5mM EDTA and 0.05% Sodium azide) for 20 minutes at 4°C following which cells were stained in suspension for anti-mouse TREM2 biotinylated (R&D systems, BAF1729) for 30 minutes at 4°C ...
-
bioRxiv - Synthetic Biology 2021Quote: ... Macrophage cell lysates were collected at 4 h post-infection and subjected to Western blot for GNLY (R&D Systems Cat# AF3138-SP), CCL20 (R&D Systems Cat# AF360-SP) ...
-
bioRxiv - Immunology 2024Quote: ... cells were stained for 40 min at 4°C with fluorophore-conjugated antibodies PE-anti-Glut1 (clone 202915 R&D Systems, Minnesota, USA) and in parallel ...
-
bioRxiv - Microbiology 2021Quote: ... 10ng/ml interleukin 4 (IL-4) and 10ng/ml transforming growth factor beta 1 (TGFβ1) (R&D systems, Minneapolis, MN), and used between days 7-9 of differentiation.
-
bioRxiv - Microbiology 2020Quote: ... Recombinant human MMP-9 protein and Recombinant mice MMP-9 protein were purchased from R&D systems. Commercialized DENV2-NS1 protein were purchased from Native Antigen ...
-
bioRxiv - Cancer Biology 2022Quote: CAR and BOXR1030 T cells were activated with immobilized recombinant GPC3 protein (0.3 mg/mL; R&D Systems, Cat# 2119-GP-050) for 4 and 24 hours ...
-
bioRxiv - Cancer Biology 2022Quote: CAR and BOXR1030 T cells were activated with immobilized recombinant GPC3 protein (0.3 ug/mL) (R&D Systems, Cat# 2119-GP-050) over a 6-day time course ...
-
bioRxiv - Neuroscience 2020Quote: ... Cells were then treated with 200ng/mL of recombinant rat NogoA (1026-1090aa) and Fc Chimera protein (Nogo-66; R&D Systems), or with human NogoA (566-748aa ...
-
bioRxiv - Bioengineering 2020Quote: The relative expression levels of cellular stress related proteins of iCMs (n=3) were analyzed using the Proteome Profiler Human Cell Stress Array (ARY018, R&D Systems), according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2019Quote: ... To induce differentiation FGF2 was withdrawn from the cell culture media and then replaced with bone morphogenic protein (BMP4; R&D Systems) or and Wnt3a (R&D Systems) ...
-
bioRxiv - Developmental Biology 2020Quote: ... BMP4 + Activin A treatment was accomplished by treating cells with mTeSR supplemented with 3 ng/mL recombinant human BMP4 protein (R&D Systems) and 100 ng/mL recombinant human Activin A protein (R&D Systems) ...
-
bioRxiv - Immunology 2022Quote: ... anti-CTLA-4 (clone 63828; R&D Systems) or with the respective isotype control ...
-
bioRxiv - Microbiology 2019Quote: ... and IL-4 (6.5ng/mL; R&D Systems) for 6 days in 37°C ...
-
bioRxiv - Immunology 2019Quote: ... 50 ng/ml IL-4 (R&D Systems); 25 mM HEPES (Quality Biology ...
-
bioRxiv - Neuroscience 2020Quote: ... and sheep anti-Teneurin-4 (R&D Systems). HRP-conjugated secondary antibodies were from Thermo-Fisher.
-
bioRxiv - Immunology 2021Quote: ... IL-4 (5.0 ng/ml; R&D Systems) and/or TGF-β (2.0 ng/ml ...
-
bioRxiv - Immunology 2021Quote: ... IL-4 (20 ng/ml; R&D Systems), IL-15 and/or IL-21 (50 ng/ml ...
-
bioRxiv - Cell Biology 2021Quote: ... and syndecan-4 (R&D Systems Cat#: FAB291819) for 15 minutes at 4°C ...
-
bioRxiv - Immunology 2022Quote: ... 5 ng/ml IL-4 (R&D Systems) and 12 ng/ml IL-10 (R&D Systems ...
-
bioRxiv - Developmental Biology 2022Quote: ... BMP-4 from R&D Systems (314-BP) was reconstituted in sterile 4 mM HCl containing 0.1% (wt/vol ...
-
bioRxiv - Immunology 2022Quote: ... and rIL-4 (0.86ng/ml, R&D Systems) for 5-6 days ...
-
bioRxiv - Pharmacology and Toxicology 2021Quote: ... 10 mU recombinant DPP-4 (R&D Systems), or no enzyme as a control for non-enzymatic degradation over the same time period ...
-
bioRxiv - Neuroscience 2023Quote: ... 1.4 nM neurotrophin 4 (NT4, R&D systems) and 1.3 nM human insulin-like growth factor 1 (hIGF-1 ...
-
bioRxiv - Immunology 2022Quote: ... IL-4 (50 ng/ml, R&D Systems) and anti-IFN-γ (10 μg/ml ...
-
bioRxiv - Immunology 2023Quote: ... rIL-4 (0.86 ng/mL, R&D system) and rGM-CSF (10 ng/mL ...
-
bioRxiv - Molecular Biology 2022Quote: ... 4 ng/ml WNT-3A (R&D Systems), 1 μM CHIR99021 M SB-431542 (Tocris) ...
-
bioRxiv - Molecular Biology 2023Quote: ... anti-Thrombospondin-4 (cat# AF2390; R&D Systems), and anti-TIMP-1 (cat# AF980 ...
-
bioRxiv - Pathology 2023Quote: ... Anti-4-Hydroxynonenal (R&D Systems; Biotechne, MAB3249); Anti-MUC2 (Abcam ...
-
bioRxiv - Cell Biology 2023Quote: ... anti-Thrombospondin-4 (cat# AF2390; R&D Systems), anti-TGF-β3 (cat# ab15537 ...
-
bioRxiv - Cell Biology 2023Quote: ... and platelet factor 4 (PF4, R&D Systems) were performed according to the manufacturer’s instructions ...
-
bioRxiv - Bioengineering 2024Quote: ... IL-4 (20 ng/mL, R&D Systems) and IL-13 (20 ng/mL ...
-
bioRxiv - Genetics 2024Quote: ... OCT-4 (1:200, AF1759, R&D Systems), NANOG (1:200,ab80892 ...
-
bioRxiv - Immunology 2021Quote: ... Sanofi-aventis Cat# NAC2004–5843-01) and interleukin-4 (IL-4; 1000 IU/mL; R&D Systems Cat# 204-1 L). Mature ...
-
bioRxiv - Biophysics 2021Quote: ... Recombinant Human EGF Protein (R&D Systems). Erlotinib hydrochloride (500nM ...
-
bioRxiv - Biochemistry 2019Quote: ... Human recombinant EGF protein (R&D Systems) was diluted to 10x in serum free medium ...
-
bioRxiv - Microbiology 2020Quote: ... C-reactive protein (CRP, R&D systems), and CCL20 (R&D Systems ...
-
bioRxiv - Microbiology 2019Quote: ... recombinant ephrinA4-Fc protein (R&D Systems) was added at the start of the coculture to a final concentration of 2µg/ml.
-
bioRxiv - Developmental Biology 2022Quote: ... and recombinant CXCL12 protein (R&D System) was added at 50ng/ml ...
-
bioRxiv - Developmental Biology 2023Quote: Recombinant Bmp proteins from R&D Systems/Biotechne (Bmp2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... and mouse CD38 proteins (R&D systems, catalog # 4947-AC ...
-
bioRxiv - Immunology 2021Quote: The expression of NKG2D ligands in tumor cell lines was assessed using Recombinant Human NKG2D Fc Chimera Protein (R&D systems, Abingdon, UK). 105 tumor cells were incubated either with 0.5 μg of NKG2D Fc recombinant protein or IgG1-Fc during 30 min ...
-
bioRxiv - Neuroscience 2022Quote: ... Cells were left for 48h to allow expression of LepRb-HA protein before treatment with recombinant murine leptin (R&D System #498-OB) at 0-10 ng/L for 30 minutes before cell lysis and western blotting for phosphoSTAT3 (Y705) ...
-
bioRxiv - Cell Biology 2024Quote: Secreted proteins were measured in cell culture supernatants from treated iBMDMs using ELISAs for IL-1β and CCL5 (Quantikine®, R&D systems).
-
bioRxiv - Cell Biology 2023Quote: ... the cells were cultured in N2B27 with 10 ng/ml mouse basic fibroblast growth factor (bFGF) recombinant proteins (R&D systems #313FB025/CF). On Day 2 ...
-
bioRxiv - Systems Biology 2023Quote: Where indicated the cells were stimulated with the final concentration of 10 ng/ml of recombinant human TNF-α protein (R&D Systems) or 100 ng/ml of recombinant human interleukin 1 beta (IL-1β ...
-
bioRxiv - Developmental Biology 2023Quote: ... Subsequently cell clusters were differentiated into β-like cells by exposure to the appropriate media as previously published.29 All recombinant proteins were purchased from R&D System unless otherwise stated (see Supplementary Table 3).
-
bioRxiv - Immunology 2020Quote: ... 1.25% of supernatant from Con-A-stimulated rat splenocytes (assay positive control), c) recombinant canine IL-4 (rcaIL-4, 360 ng/mL) (R&D Systems), d ...
-
bioRxiv - Cancer Biology 2021Quote: ... supplemented with GM-CSF (1000 U/mL) and IL-4 (1000 U/mL) or GM-CSF & IL-4 (20 and 40 ng/mL, R&D Systems) and seeded into 24-well low binding plates at 1 × 106 cells/well ...
-
bioRxiv - Physiology 2021Quote: ... Cells were then incubated overnight at 4°C with goat anti-mouse platelet endothelial cell adhesion molecule (CD31/PECAM-1) primary antibody (R&D Systems cat. No. AF3628) diluted in antibody buffer (1:1000 ...